By CapitalSnitch Research Desk · updated Oct 11, 2026 · data from SEC filings and official Congress disclosures
Insider activity at Teva Pharmaceutical Industries Ltd has been all selling for a year now: about $113.3 million from 14 sellers, and zero buyers on the open market.
Keep in mind most insider selling is routine — stock-based pay has to be converted to cash at some point.
On the institutional side, 673 funds reported holding TEVA at the end of Q2 2026, and more funds bought than sold. Members of Congress reported 1 trade in TEVA over the past two years (one member). Looking at the quarterly pattern: 7 quarters in a row of net selling by insiders. Insiders bought in 1 of the last 7 full quarters.
Are insiders buying or selling TEVA stock?
In the last 12 months Teva Pharmaceutical Industries Ltd insiders made open-market purchases worth about $0 and sales worth about $113.3 million. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.
When was the last insider trade in TEVA?
The most recent open-market insider trade in TEVA was filed on 2026-09-22.
How many institutions own TEVA?
673 investment managers reported holding TEVA in SEC Form 13F filings for Q2 2026.
Has any member of Congress traded TEVA?
Yes. Members of Congress reported 1 trades in TEVA over the past two years. The full list is free on CapitalSnitch.
Free weekly email: the week's biggest insider buys and Congress trades, every Monday. No spam, one-click unsubscribe.
Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1).
Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).